Cancer metabolism
The regulation of metabolic reactions in the cancer cell or the surrounding stroma generate intermediates that are at the key of cancer pathogenesis, progression, and therapy resistance. Tumours exhibit a wide range of varieties in molecular alterations that merge in metabolic reprogramming. Warburg’s work focused on the metabolic reprogramming of cancer cells, which is now consider as one of the hallmarks of cancer as put forward by Douglas Hanahan and Robert Weinberg in Hallmarks of Cancer. The metabolic profile observed in cancer cells often shows increased consumption of glucose and glutamine, increased glycolysis, alterations in the use of metabolic enzyme isoforms, and increased secretion of lactate. The hallmarks of cancer are Deregulated cellular energetics, sustaining proliferative signaling, Evading growth suppressors, Avoiding immune destruction, Enabling replicative immortality, Tumour promoting inflammation, Resisting cell death.
Related Conference of Cancer metabolism
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Cancer metabolism Conference Speakers
Recommended Sessions
- Analytical techniques
- Cancer metabolism
- Carbohydrates in metabolism
- Exometabolomics
- Immuno Metabolomics
- Lipids metabolism
- Mass spectroscopy based metabolomics
- Metabolic Fingerprinting
- Metabolic Pathways
- Metabolic Profiling
- Metabolic syndrome
- Metabolism
- Metabolism Syndrome Treatments
- Metabolites
- Metabolome
- Metabolomics
- Metabolomics Approaches
- Metabolomics in various Diseases
- Metabonomics
- Minerals and vitamins in metabolism
- NMR Spectroscopy Based Metabolomics
- Plant Metabolomics
- Proteins Metabolism
- Rare Metabolic Disorder
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
